There are 2 papers on phospho-tau 181 in aging research: 2 trials in people.
2 papers study it4 more mention it1 finding
See all 6 papers on phospho-tau 181
“Both biomarkers’ levels were statistically significantly higher in the ARHL group compared to the control group (p < 0.0001).”
- Human trial2
Associations
1Age-related hearing loss
upin humans1
1 study
Age-related hearing loss
upin humans1
Age-related hearing loss is associated with phospho-tau 181 in humans.
“Both biomarkers’ levels were statistically significantly higher in the ARHL group compared to the control group (p < 0.0001).”
Human trialn = 50
Journal of clinical medicine
Latest
Journal of Clinical Medicine
Blood Neurofilament Light Chain and Phospho-Tau 181 in Subjects with Mild Cognitive Impairment Due to Age-Related Hearing Loss
Non-randomized trial in 30 peopleHearing impairment
Neurology
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
Randomized trial in 119 peopleResveratrol
Aging and Disease
Dysregulation of Lipid Metabolism Serves as A Link Between Alzheimer's and Cardiovascular Disease, As Witnessed in A Cross-Sectional Study
Cross-sectional study in peopleAlzheimer's disease
Alzheimer's Research & Therapy
The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study
Cohort study of 1,189 peopleNfL
European Archives of Oto-rhino-laryngology
Clinical significance of the cognition-related pathogenic proteins in plasma neuronal-derived exosomes among normal cognitive adults over 45 years old with olfactory dysfunction
Cross-sectional study of 29 peopleOlfactory dysfunction
Alzheimer's Research & Therapy
Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults
Cross-sectional study of 331 peopleAlzheimer's disease